Spire Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-285
Closed -$5.26K 2512
2024
Q4
$5.26K Hold
285
﹤0.01% 2033
2024
Q3
$6.19K Hold
285
﹤0.01% 1770
2024
Q2
$5.59K Sell
285
-474
-62% -$9.9K ﹤0.01% 1802
2024
Q1
$16.5K Hold
759
﹤0.01% 1572
2023
Q4
$19.9K Hold
759
﹤0.01% 1539
2023
Q3
$20.3K Hold
759
﹤0.01% 1497
2023
Q2
$28.1K Hold
759
﹤0.01% 1443
2023
Q1
$23.7K Buy
759
+474
+166% +$15.3K ﹤0.01% 1553
2022
Q4
$8K Sell
285
-484
-63% -$17.3K ﹤0.01% 1689
2022
Q3
$29K Sell
769
-608
-44% -$30.5K ﹤0.01% 1162
2022
Q2
$75K Sell
1,377
-340
-20% -$18.7K ﹤0.01% 1143
2022
Q1
$107K Buy
1,717
+342
+25% +$22.5K ﹤0.01% 1139
2021
Q4
$138K Buy
1,375
+134
+11% +$11.8K ﹤0.01% 1270
2021
Q3
$112K Buy
1,241
+293
+31% +$26.6K ﹤0.01% 1152
2021
Q2
$87K Sell
948
-109
-10% -$8.7K ﹤0.01% 1233
2021
Q1
$102K Buy
+1,057
New +$109K ﹤0.01% 1395

Other funds holding FLGT

Spire Wealth Management's FLGT Position: Q1 2025 in Review

Spire Wealth Management sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 285 shares — an estimated $5.26K sold.

Spire Wealth Management first reported a position in FLGT in Q1 2021 and held it in 16 quarters. The position peaked at $138K in Q4 2021. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Spire Wealth Management reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Spire Wealth Management sold 285 Fulgent Genetics shares in Q1 2025, an estimated $5.26K.
  • Spire Wealth Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 16 quarters.
  • Spire Wealth Management's Fulgent Genetics position peaked at $138K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Spire Wealth Management's 13F filing for Q1 2025, filed 23 Apr 2025.